Image de couverture de livre

Efficacy and Safety of Oral Semaglutide in the Treatment of Type 2 Diabetes: A Meta‐Analysis

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Lin Zhang, Zixin Hua, Zhenwei Fang, Juanjuan Wei, Yang Lin
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	The Journal of Clinical Pharmacology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Efficacy of Bile Acid Sequestrants in the Treatment of Bile Acid Diarrhea: A Meta‐Analysis of Randomized Controlled Trials
par: Giulia Almiron R. Soares, et autres
Publié: (2024)

Influence of Dapagliflozin Dosing on Low‐Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus: A Systematic Literature Review and Meta‐Analysis
par: Srinivas Martha, et autres
Publié: (2024)

Population Pharmacokinetics and Exposure‐Response Analyses for Ubrogepant Efficacy and Safety in the Acute Treatment of Migraine: Analysis of Phase 1–3 Studies
par: Sven Stodtmann, et autres
Publié: (2026)

Efficacy, Safety, and Population Pharmacokinetics of Eltrombopag in Children with Different Severities of Aplastic Anemia
par: Wei Zhang, et autres
Publié: (2024)

Efficacy and Safety of Different 5‐HT3 Receptor Antagonists as Monotherapy for Preventing Nausea and Vomiting in Patients Undergoing Surgery or Chemotherapy: A Network Meta‐Analysis of Randomized Controlled Trials
par: Hong Sun, et autres
Publié: (2025)

A Meta‐Analysis of the Safety and Immunogenicity of Pharmacokinetic Similarity Studies and Comparative Clinical Studies
par: Ping Ji, et autres
Publié: (2024)

Contemporary Use of Oral Inotropes in the Outpatient Treatment of Heart Failure: Analysis of a Japanese Nationwide Database
par: Michikazu Nakai, et autres
Publié: (2025)

Exposure‐Efficacy Analysis and Dopamine D2 Receptor Occupancy in Adults with Schizophrenia after Treatment with the Monthly Intramuscular Injectable Risperidone ISM
par: Andreas Lindauer, et autres
Publié: (2024)

Efficacy of Low‐Dose Scopolamine and Palonosetron in Reducing Immediate Post‐Gastrointestinal Endoscopy Nausea and Vomiting: A Prospective, Randomized, Controlled Study
par: Jianghuai Lin, et autres
Publié: (2024)

Efficacy and Safety of Janus Kinase Inhibitors in Patients with Vitiligo: A Systematic Review and Meta‐Analysis
par: Fan Huang, et autres
Publié: (2024)

Comparative Safety of Tenecteplase and Alteplase in Direct Oral Anticoagulant‐Pretreated Patients With Acute Ischemic Stroke
par: Hsu‐Wei Lin, et autres
Publié: (2025)

A Retrospective Analysis of PK and Response of Oral Ibuprofen in the Treatment of a Patent Ductus Arteriosus in Extremely Low Gestational Age Neonates
par: Mohd Asif, et autres
Publié: (2025)

Population Pharmacokinetics of Valemetostat and Exposure–Response Analyses of Efficacy and Safety in Patients with Relapsed/Refractory Peripheral T–Cell Lymphoma
par: Hiroyuki Inoue, et autres
Publié: (2025)

From Genotype to Therapeutic Monitoring: Enhancing Tamoxifen Efficacy in Breast Cancer Treatment
par: Ana Flávia Mendes Batista, et autres
Publié: (2025)

Semaglutide use is associated with neuromuscular junction degradation in older adults with type II diabetes mellitus
par: Rizwan Qaisar, et autres
Publié: (2025)

Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Budesonide Oral Suspension in Healthy Adult Participants: A Randomized Phase 1 Study
par: Alexander J. Prokopienko, et autres
Publié: (2024)

Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR ‐1, ‐2, and ‐3, in Patients with Refractory Metastatic Colorectal Cancer
par: Xiaofei Zhou, et autres
Publié: (2025)

Establishing a Quantitative Framework for Combined Oral Contraceptives: Evaluating the Impact of Drug–Drug Interactions on Exposure and Clinical (Surrogate) Efficacy Endpoints
par: Dain Chun, et autres
Publié: (2025)

Comparing the Efficacy of Various Insulin Types: Pharmacokinetic and Pharmacodynamic Modeling of Glucose Clamp Effects in Healthy Volunteers
par: Yi Chien Chang, et autres
Publié: (2025)

Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Proline Henagliflozin in Chinese Subjects with Varying Degrees of Liver Dysfunction
par: Likun Ding, et autres
Publié: (2024)

Characterizing Cellular Expansion of Idecabtagene Vicleucel and Association with Clinical Efficacy and Safety in Patients with Triple‐Class‐Exposed Relapsed/Refractory Multiple Myeloma
par: Fan Wu, et autres
Publié: (2025)

Comment on “Population Pharmacokinetics of Valemetostat and Exposure–Response Analyses of Efficacy and Safety in Patients with Relapsed/Refractory Peripheral T‐Cell Lymphoma”
par: Manish R. Bhise, et autres
Publié: (2025)

Pharmacokinetics, Safety, and Tolerability of GS‐1427, an Oral Prodrug of a Potent and Selective α4β7 Integrin Inhibitor, in Healthy Participants
par: Jin Zhou, et autres
Publié: (2026)

Phase 1 Safety and Pharmacokinetics Study of TAVO101, an Anti‐Human Thymic Stromal Lymphopoietin Antibody for the Treatment of Allergic Inflammatory Conditions
par: Chao Han, et autres
Publié: (2024)

Intranasal Naloxone During Recurrent Exercise in Individuals with Type‐1 Diabetes Mellitus: Evaluation of the Clinical Predictors of Pharmacokinetics and Exposure–Response
par: Omar N. Al Yacoub, et autres
Publié: (2025)

Physiologically Based Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Analysis for Ceftriaxone Dosing in Pregnant Women: Model Development and Clinical Applications
par: Xinyue Chen, et autres
Publié: (2026)

Elranatamab Exposure–Safety Analysis in Relapsed or Refractory Multiple Myeloma
par: Pooneh Soltantabar, et autres
Publié: (2025)

Effect of Histamine H2 Receptor Antagonists on All‐Cause Mortality in Critically Ill Patients With Essential Hypertension: A Retrospective Cohort Study
par: Jian‐Mei Pan, et autres
Publié: (2024)

Randomized, Placebo‐Controlled, First‐in‐Human Study of the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Oral Doses of Novel Antitubercular Drug Candidate, GSK2556286, in Healthy Adults
par: Emma Ilsley, et autres
Publié: (2026)

Pharmacometric Analysis to Describe Pharmacokinetics and Exposure‐Efficacy Response of Ivermectin in Adolescents Infected with Trichuris trichiura
par: David T. Ajayi, et autres
Publié: (2024)

Safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of HRS‐1893, a cardiac myosin inhibitor, in healthy subjects
par: Kexu Yang, et autres
Publié: (2026)

Efficacy and Safety of Clopidogrel With and Without a Proton Pump Inhibitor: A Systematic Review and Meta‐Analysis
par: Magnus A. B. Axelsson, et autres
Publié: (2025)

Population Pharmacokinetics of Oral Gecacitinib in Healthy Subjects and Patients with Autoimmune and Inflammatory Diseases
par: Qingheng Meng, et autres
Publié: (2026)

Population Pharmacokinetic Analysis of Dolutegravir in Treatment‐Experienced Adults Living with HIV‐1
par: Hardik Chandasana, et autres
Publié: (2024)

A Randomized Crossover Clinical Study to Assess the Effect of Oral Nicotine Pouches Used for Different Durations on Plasma Nicotine Pharmacokinetics in Healthy Oral Pouch Consumers
par: David Azzopardi, et autres
Publié: (2025)

A Simulation‐Based Assessment of Levetiracetam Concentrations Following Fixed and Weight‐Based Loading Doses: A Meta‐Regression and Pharmacokinetic Modeling Analysis
par: Anthony Lau, et autres
Publié: (2024)

Pharmacodynamic Exposure–Response Analysis of Fracture Count Data Following Treatment with Burosumab in Patients with XLH
par: Krina Mehta, et autres
Publié: (2024)

Methoxyethyl Etomidate Hydrochloride (ET‐26): A Phase I Clinical Trial Assessing Drug–Drug Interactions in Healthy Subjects
par: Fan Yang, et autres
Publié: (2025)

A Phase 1 Study of the Pharmacokinetics, Safety, and Tolerability of Posdinemab (JNJ‐63733657) in Healthy Chinese Adults
par: Fangfang Wang, et autres
Publié: (2025)

Pregnancy Outcomes After Semaglutide Exposure
par: Line Kolding, et autres
Publié: (2025)